Ischemic modified albumin increases in acute kidney injury

1. Chawla LS, Amdur RL, Shaw AD, Faselis C, Palant CE, Kimmel PL. Association between AKI and longterm renal and cardiovascular outcomes in united states veterans. Clin J Am Soc Nephrol. 2014;9(3):448-56. DOI: 10.2215/CJN.0244021310.2215/CJN.02440213394475324311708Open DOISearch in Google Scholar

2. Bellomo R, Auriemma S, Fabbri A, D’Onofrio A, Katz N, McCullough PA, et al. The pathophysiology of cardiac surgery-associated acute kidney injury (CSAAKI). Vol. 31, International Journal of Artificial Organs. 2008. p. 166-78.10.1177/03913988080310021018311733Search in Google Scholar

3. Nangaku M, Rosenberger C, Heyman SN, Eckardt KU. Regulation of hypoxia-inducible factor in kidney disease. Clin Exp Pharmacol Physiol. 2013;40(2):148-57. DOI: 10.1111/1440-1681.1200510.1111/1440-1681.1200522905709Open DOISearch in Google Scholar

4. Yousefipour Z, Oyekan A, Newaz M. Interaction of oxidative stress, nitric oxide and peroxisome proliferator activated receptor gamma in acute renal failure. Pharmacol Ther. 2010;125(3):436-45. DOI: 10.1016/j. pharmthera.2009.12.00410.1016/j.pharmthera.2009.12.00420117134Open DOISearch in Google Scholar

5. Verma P, Bhattacharya SN, Banerjee BD, Khanna N. Oxidative stress and leukocyte migration inhibition response in cutaneous adverse drug reactions. Indian J Dermatol Venereol Leprol. 2012;78(5):664. DOI: 10.4103/0378-6323.10051910.4103/0378-6323.10051922960836Open DOISearch in Google Scholar

6. Devarajan P. Neutrophil gelatinase-associated lipocalin - An emerging troponin for kidney injury. Vol. 23, Nephrology Dialysis Transplantation. 2008. p. 3737-43. DOI: 10.1093/ndt/gfn53110.1093/ndt/gfn531272081618809975Open DOISearch in Google Scholar

7. Gaut JP, Crimmins DL, Ohlendorf MF, Lockwood CM, Griest TA, Brada NA, et al. Development of an immunoassay for the kidney-specific protein myo-inositol oxygenase, a potential biomarker of acute kidney injury. Clin Chem. 2014;60(5):747-57. DOI: 10.1373/clinchem.2013.21299310.1373/clinchem.2013.212993412857824486646Open DOISearch in Google Scholar

8. Petrica L, Gluhovschi A, Gluhovschi C, Gadalean F, Balgradean C, Groza C, et al. Proximal tubule dysfunction in renal diseases - diagnostic significance of proteomics and biomarkers. Rev Romana Med Lab. 2012;20(2):97-107.Search in Google Scholar

9. Şalaru DL, Macovei L, Stătescu C, Arsenescu-Georgescu C. Assessement of microalbuminuria in hypertensive patients with established coronary artery disease. Rev Romana Med Lab. 2013;21(4):407-14. DOI: 10.2478/rrlm-2013-004110.2478/rrlm-2013-0041Open DOISearch in Google Scholar

10. Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Dragun D, et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study. Crit Care Med. 2009;37(2):553-60. DOI: 10.1097/CCM.0b013e318195846e10.1097/CCM.0b013e318195846e19114878Search in Google Scholar

11. Leslie JA, Meldrum KK. The Role of Interleukin-18 in Renal Injury. J Surg Res. 2008;145(1):170-5. DOI: 10.1016/j.jss.2007.03.03710.1016/j.jss.2007.03.03717658553Open DOISearch in Google Scholar

12. Schrezenmeier E V, Barasch J, Budde K, Westhoff T, Schmidt-Ott KM. Biomarkers in acute kidney injury - pathophysiological basis and clinical performance. Acta Physiol (Oxf). 2016; Disponible: http://www.ncbi.nlm.nih.gov/pubmed/2747447310.1111/apha.12764557583127474473Search in Google Scholar

13. Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med. 2010;4(2):265-80. DOI: 10.2217/bmm.10.1210.2217/bmm.10.12289314820406069Open DOISearch in Google Scholar

14. Ellidag HY, Eren E, Yilmaz N, Bayindir A. Ischemia Modified Albumin Levels and Increased Oxidative Stress in Patients With Multiple Myeloma / Nivoi Albumina Modifikovanog Ishemijom I Povi[Eni Oksidantni Stres Kod Pacijenata Sa Multiplim Mijelomom. J Med Biochem. 2013;33(2):175-80. DOI: 10.2478/jomb-2013-002710.2478/jomb-2013-0027Open DOISearch in Google Scholar

15. Pantazopoulos I, Papadimitriou L, Dontas I, Demestiha T, Iakovidou N, Xanthos T. Ischaemia modified albumin in the diagnosis of acute coronary syndromes. Vol. 80, Resuscitation. 2009. p. 306-10. DOI: 10.1016/j.resuscitation. 2008.10.03510.1016/j.resuscitation.2008.10.035Search in Google Scholar

16. Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, et al. Evaluation of ischaemia-modified albumin as a marker of myocardial ischaemia in endstage renal disease. Clin Sci (Lond). 2007;113(1):25-32. DOI: 10.1042/CS2007001510.1042/CS2007001517284166Open DOISearch in Google Scholar

17. Dursun A, Okumus N, Zenciroglu A. Ischemia- modified albumin (IMA): could it be useful to predict perinatal asphyxia? J Matern Fetal Neonatal Med. 2012;25(11):2401-5. DOI: 10.3109/14767058.2012.69794310.3109/14767058.2012.69794322642562Open DOISearch in Google Scholar

18. Kotani K, Kimura S, Gugliucci A. Paraoxonase-1 and ischemia-modified albumin in patients with end-stage renal disease. J Physiol Biochem. 2011;67(3):437-41. DOI: 10.1007/s13105-011-0092-410.1007/s13105-011-0092-421484479Open DOISearch in Google Scholar

19. Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes - Review and clinical implications. Clin Chem Lab Med. 2011;49(2):177-84. DOI: 10.1515/CCLM.2011.03710.1515/CCLM.2011.03721083441Open DOISearch in Google Scholar

20. Shen XL, Lin CJ, Han LL, Lin L, Pan L, Pu XD. Assessment of ischemia-modified albumin levels for emergency room diagnosis of acute coronary syndrome. Int J Cardiol. Elsevier Ireland Ltd; 2011;149(3):296-8.10.1016/j.ijcard.2010.01.013Search in Google Scholar

21. Yilmaz H, Cakmak M, Inan O, Darcin T, Akcay A. Can neutrophil-lymphocyte ratio be independent risk factor for predicting acute kidney injury in patients with severe sepsis? Ren Fail. 2015;37(2):225-9. DOI: 10.3109/0886022X.2014.98247710.3109/0886022X.2014.98247725394529Open DOISearch in Google Scholar

22. Velibey Y, Oz A, Tanik O, Guvenc TS, Kalenderoglu K, Gumusdag A, et al. Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Angiology. 2017 May;68(5):419-27. DOI: 10.1177/0003319716660244 10.1177/000331971666024427473864Open DOISearch in Google Scholar

23. Han JS, Park KS, Lee MJ, Kim CH, Koo HM, Doh FM, et al. Mean platelet volume is a prognostic factor in patients with acute kidney injury requiring continuous renal replacement therapy. J Crit Care; 2014;29(6):1016-21. DOI: 10.1016/j.jcrc.2014.07.02210.1016/j.jcrc.2014.07.02225138689Search in Google Scholar

24. Kellum J a, Lameire N, Aspelin P, Barsoum RS, Burdmann E, Goldstein SL, et al. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2(1):1-138.Search in Google Scholar

25. Andringa KK, Agarwal A. Role of hypoxia-inducible factors in acute kidney injury. Nephron - Clin Pract. 2014;127(1-4):70-4. DOI: 10.1159/00036366910.1159/00036366925343825Open DOISearch in Google Scholar

26. Kiyici A, Mehmetoglu I, Karaoglan H, Atalay H, Solak Y, Türk S. Ischemia-modified albumin levels in patients with end-stage renal disease patients on hemodialysis: does albumin analysis method affect albumin-adjusted ischemia-modified albumin levels? J Clin Lab Anal. 2010;24(4):273-7. DOI: 10.1002/jcla.2039910.1002/jcla.20399664757820626021Open DOISearch in Google Scholar

27. Kurtul A, Yarlioglues M, Duran M, Murat SN. Association of Neutrophil-to-lymphocyte Ratio with Contrast- induced Nephropathy in Patients with Non-ST-elevation Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention. Hear Lung Circ. 2016;25(7):683-90. DOI: 10.1016/j.hlc.2016.01.00710.1016/j.hlc.2016.01.00726935164Open DOISearch in Google Scholar